Doctoral Researcher
(Alumni)
Medical Center – University of Freiburg
Department of Medical Microbiology and Hygiene, Institute for Virology
- +49 (o) 761/ 203 – 6642
- daniel.schnepf@uniklinik-freiburg.de
- Homepage
| since 2016 | PhD student in the lab of Prof. Dr. Peter Stäheli, Department for Medical Microbiology and Hygiene (DMMH), Institute for Virology, Medical Center - University of Freiburg |
| 2013 – 2016 | M. Sc. in Molecular Medicine, University of Freiburg, Germany |
| 2010 – 2013 | B. Sc. in Molecular Medicine, University of Freiburg, Germany |
Publications based on CRC1160 funding
Schnepf D, Crotta S, Thamamongood T, Stanifer M, Polcik L, Ohnemus A, Vier J, Jakob C, Llorian M, Gad HH, Hartmann R, Strobl B, Kirschnek S, Boulant S, Schwemmle M, Wack A, Staeheli P. 2021. Selective Janus kinase inhibition preserves interferon-λ-mediated antiviral responses. Sci Immunol. 6(59):eabd5318. doi: 10.1126/sciimmunol.abd5318.
Mezö C, Dokalis N, Mossad O, Staszewski O, Neuber J, Yilmaz B, Schnepf D, de Agüero MG, Ganal-Vonarburg SC, Macpherson AJ, Meyer-Luehmann M, Staeheli P, Blank T, Prinz M, Erny D. 2020. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease. Acta Neuropathol Commun. 8(1):119. doi: 10.1186/s40478-020-00988-5.
Gebhardt, A., V. Bergant, D. Schnepf, M. Moser, A. Meiler, D. Togbe, C. Mackowiak, L. S. Reinert, S. R. Paludan, B. Ryffel, A. Stukalov, P. Staeheli, and A. Pichlmair. 2019. The alternative cap-binding complex is required for antiviral defense in vivo. PLoS Pathog 15: e1008155.
